Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial

BACKGROUND: The identification and treatment of LTBI is a key component of the WHO’s strategy to eliminate TB. Recent migrants from high TB-incidence countries are recognised to be at risk TB reactivation, and many high-income countries have focused on LTBI screening and treatment programmes for thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Burman, M., Copas, A., Zenner, D., Hickson, V., Gosce, L., Trathen, D., Ashcroft, R., Martineau, A. R., Abubakar, I., Griffiths, C., Kunst, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884916/
https://www.ncbi.nlm.nih.gov/pubmed/31783742
http://dx.doi.org/10.1186/s12889-019-7983-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884916/
https://www.ncbi.nlm.nih.gov/pubmed/31783742
http://dx.doi.org/10.1186/s12889-019-7983-7

Ejemplares similares